Renal Cancer - Results from #1020

Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19. March 16, 2023

Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy. March 16, 2023

Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model. March 15, 2023

Multiparametric magnetic resonance imaging for characterizing renal tumors: A validation study of the algorithm presented by Cornelis et al. March 15, 2023

The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm. March 14, 2023

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. March 14, 2023

B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis. March 13, 2023

Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced CT images. March 13, 2023

Superiority of magnetic resonance imaging in small renal mass diagnosis where image reports mismatches between computed tomography and magnetic resonance imaging. March 10, 2023

Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-Analysis. March 10, 2023

Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients. March 9, 2023

The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis. March 9, 2023

The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery. March 8, 2023

Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era. March 8, 2023

The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training. March 8, 2023

Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab. March 7, 2023

Factors associated with clinical trial participation for patients with renal cell carcinoma. March 7, 2023

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. March 6, 2023

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy. March 6, 2023

Comprehensive Management of Renal Masses in Solitary Kidneys. March 6, 2023

Page 52 of 455